Insider Selling: Synopsys (NASDAQ:SNPS) Insider Sells $11,044,000.00 in Stock

Synopsys, Inc. (NASDAQ:SNPSGet Free Report) insider Geus Aart De sold 25,000 shares of Synopsys stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $441.76, for a total value of $11,044,000.00. Following the completion of the transaction, the insider directly owned 120,421 shares of the company’s stock, valued at approximately $53,197,180.96. This represents a 17.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Geus Aart De also recently made the following trade(s):

  • On Tuesday, September 1st, Geus Aart De sold 24,641 shares of Synopsys stock. The stock was sold at an average price of $419.44, for a total value of $10,335,421.04.
  • On Friday, August 28th, Geus Aart De sold 25,000 shares of Synopsys stock. The stock was sold at an average price of $445.55, for a total transaction of $11,138,750.00.

Synopsys Stock Up 0.3%

Shares of SNPS traded up $1.15 during mid-day trading on Wednesday, reaching $415.97. The company’s stock had a trading volume of 1,268,643 shares, compared to its average volume of 1,994,018. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. Synopsys, Inc. has a 12-month low of $366.00 and a 12-month high of $615.79. The stock has a market cap of $79.72 billion, a PE ratio of 73.49, a price-to-earnings-growth ratio of 2.41 and a beta of 1.23. The company’s 50 day moving average is $415.20 and its 200 day moving average is $439.99.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. The firm had revenue of $2.48 billion during the quarter, compared to analysts’ expectations of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. Synopsys’s quarterly revenue was up 42.4% compared to the same quarter last year. During the same period in the previous year, the company earned $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Equities analysts anticipate that Synopsys, Inc. will post 11 EPS for the current fiscal year.

Institutional Investors Weigh In On Synopsys

Hedge funds have recently modified their holdings of the stock. BlackRock Inc. bought a new position in Synopsys in the 2nd quarter worth approximately $7,228,099,000. State Street Corp boosted its holdings in shares of Synopsys by 0.3% in the fourth quarter. State Street Corp now owns 8,788,890 shares of the semiconductor company’s stock valued at $4,128,317,000 after acquiring an additional 28,532 shares in the last quarter. Morgan Stanley raised its stake in shares of Synopsys by 2.5% in the 4th quarter. Morgan Stanley now owns 4,573,980 shares of the semiconductor company’s stock worth $2,148,491,000 after buying an additional 109,917 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Synopsys by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 4,310,846 shares of the semiconductor company’s stock valued at $2,017,256,000 after acquiring an additional 54,329 shares during the last quarter. Finally, Van ECK Associates Corp increased its holdings in shares of Synopsys by 19.7% in the second quarter. Van ECK Associates Corp now owns 3,457,249 shares of the semiconductor company’s stock valued at $1,542,175,000 after buying an additional 569,687 shares in the last quarter. 85.47% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

SNPS has been the subject of a number of recent research reports. Mizuho decreased their price target on shares of Synopsys from $600.00 to $550.00 and set an “outperform” rating for the company in a research note on Thursday, August 27th. Robert W. Baird raised shares of Synopsys from a “neutral” rating to an “outperform” rating and upped their target price for the company from $558.00 to $560.00 in a report on Thursday, August 27th. Stifel Nicolaus upped their price objective on shares of Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Wells Fargo & Company reduced their price target on Synopsys from $535.00 to $450.00 and set an “equal weight” rating for the company in a report on Tuesday, August 11th. Finally, Needham & Company LLC restated a “buy” rating and set a $580.00 target price on shares of Synopsys in a research report on Thursday, August 27th. Twelve research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $561.28.

Get Our Latest Analysis on SNPS

About Synopsys

(Get Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Insider Buying and Selling by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.